版本:
中国

BRIEF-Bellerophon Q1 loss per share $0.60

May 15 Bellerophon Therapeutics Inc:

* Bellerophon reports first quarter 2017 financial results and provides business update

* Q1 loss per share $0.60

* Bellerophon Therapeutics - believes that as of march 31, 2017, it has sufficient funds to satisfy its operating cash needs for at least next 12 months

* Bellerophon Therapeutics - at March 31, 2017, co had cash and cash equivalents, restricted cash and marketable securities of $17.1 million compared to $20.5 million at December 31, 2016 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐